Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer

Robert F. Marschke, Joseph P. Grill, Jeff A. Sloan, Donald B. Wender, Ralph Levitt, James A. Mailliard, James B. Gerstner, Chirantan Ghosh, Roscoe F. Morton, James R. Jett

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences